Professor Andrew Porter holds Executive and Non-Executive positions in Life Science and other businesses. He is part-time Professor of Biotechnology at the University of Aberdeen and has a wealth of experience working with academia and industry.
Andrew founded Haptogen Ltd and was on the Board of NovaBiotics Ltd. He was one of the founders of drug discovery company Elasmogen and manage their patent portfolio and IP strategy. As Chair at Roslin Technologies Ltd. he helps to commercialise their animal stem cell platforms.
He has helped establish a small portfolio of award winning cocktail bars and Aberdeen’s first gin distillery for 100 years, Langstane Liquor.